Losner S., Volk BW and Wilensky ND: Fibrinogen concentration in acute myocardial infarction. Arch Intern Med93:231, 1954.
3.
Fulton RM, Duckett K.: Plasma fibrinogen and thromboembolism after myocardial infarction . Lancet11:1161, 1976.
4.
Sharma SC and Seth HN: Platelet adhesiveness, plasma fibrinogen and fibrinolytic activity in acute myocardial infarction. Br Heart J40:526, 1978.
5.
Gidron E., Magelit R., Oliven A. and Shalitin Y.: Effects of myocaridal infarction on components of fibrinolytic system . Br Heart J39:19, 1977.
6.
Goodnight SH , Rapaport SI and Zivelin A.: Fibrinogen levels after inflammation or endotoxin in normal and hypophysectomised rats. Am J Physiol228:1575, 1975.
7.
Innes D. and Sevitt S.: Coagulation and fibrinolysis in injured patients. J Clin Pathol17:1, 1964.
8.
Everett MR: Medical Biochemistry, Second Edition. New York , Paul Bottoeber Inc., 1946, p. 70.
9.
Dormandy JA: Role of fibrinogen in peripheral circulatory disease. In: International Conference on Atherosclerosis, ed. by Carlson LA, et al. New York, Raven Press, 1978, p. 409.
10.
Dormany JA, Hoon E., Khatabb AM, et al: Prognostic significance of rheological and biochemical findings in patients with intermittent claudication. Br Med J4:581, 1973.
11.
Marcel GA: Red cell deformity: Phsyiological, clinical and pharmacological aspects . J Med10:409, 1979.
12.
Cristal N., Peterburg F. and Shahar J.: Atrial fibrillation in acute myocardial infarction. Chest70:8, 1976.
13.
Thorp J., Horsfell Stone M.: A new sensitive micronephelometer. Med Biol Beng5:51, 1967.
14.
Cotton RC, Bloor K. and Archibald G.: Interrelationships between platelet response to adenosine diphosphate, blood coagulation and serum lipids in patients with peripheral occlusive atherosclerosis . Atherosclerosis16:337, 1972.
15.
Eastham RD and Morgan FN: Plasma fibrinogen levels in coronary artery disease. Lancet2:1196, 1963.
16.
Lengsjen PH and Inmon TW: Haemorheologic observations in acute myocardial infarction. Angiology19:247, 1968.
17.
Cristal N., Slonim A., Hogey Z., et al: Plasma fibrinogen levels as an indicator of myocardial necrosis . J Roy Coll Phys16:57, 1982.
18.
Harker LA and Schlichter SJ: Platelet and fibrinogen consumption in man. N Engl J Med287:999, 1972.
19.
Wardle CW, Piercy DA and Anderson J.: Some chemical indices of diabetic vascular disease. Postgrad Med J49:19, 1973.
20.
Hart A., Cohen H. and Thorp JM: Effect of clofibrate in lowering plasma fibrinogen and lipoproteins in diabetic patients with vascular complications. 12th Int Congress Internal Med, Karger- Basel , 1974, p. 106.
21.
Ogston CM and Ogston D.: Plasma fibrinogen and plasminogen level in health and ischemic heart disease . J Clin Pathol19:352, 1966.
22.
McDonald S. and Edgill M.: Changes in coagulability of the blood in various phases of ischaemic heart disease. Lancet1:1115, 1959.
23.
Cristal N., Slonim A. and Alexander I.: Study on the factors affecting viscosity in coronary patients. VIII World Congress of Cardiology, Tokyo, 1978.
24.
Pola P. and Savi L.: Fibrinogenaemia determined immunonephelometrically as a possible parameter in the evaluation of peripheral atherosclerotic arteriopathy. Atherosclerosis29:205, 1978.
25.
Pilgrim LO: Abnormalities in clotting and thrombolysis as a risk factor for stroke . Thromb Diath Haemorrh31:264, 1974.
26.
Chien S.: The Red Blood Cell. Academic Press, New York, 1975.
27.
Merrill EW, Cheng CS and Pelliteer GN: Yield stress of normal human blood as a function of endogenous fibrinogen . J Appl Physiol26:13, 1969.